Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (17)
Podcast
  • (-) Conference News
  • ISET (6)
  • AHA (3)
  • ESC (2)
  • VIVA (2)
  • ACC (1)
  • EuroPCR (1)
  • SCCT (1)
  • TCT (1)
  • Endovascular (10)
  • Clinical Cardiology (7)
  • Femoral (7)
  • Coronary (6)
  • Popliteal/Infrapopliteal (5)
  • Clinical Pharma (4)
  • Prevention (4)
  • CAD Pharma (3)
  • ACS/AMI (2)
  • Diabetes (2)
  • Aortic (1)
  • Aortic Valve (1)
  • Carotid (1)
  • Congenital (1)
  • CT/CT-FFR (1)
  • DES/BRS/DCB (1)
  • Imaging & Physiology (1)
  • Left Atrial Appendage (1)
  • Lipids (1)
  • Mitral Valve (1)
  • Plaque Modification (1)
  • Policy & Practice (1)
  • Stroke (1)
  • Structural Heart (1)
  • Tricuspid Valve (1)
  • (-) 2017 (17)
Displaying 1 - 17 of 17
Sort: Relevancy | Date
Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events
News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan
Michael O'Riordan
November 17, 2017
Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear
News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale
Todd Neale
November 14, 2017
AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More
News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood
Shelley Wood
November 09, 2017
Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians
News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles
Ashley Lyles
November 06, 2017
Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD
News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown
L.A. McKeown
September 18, 2017
ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA
News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown
L.A. McKeown
September 15, 2017
VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?
News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood
Shelley Wood
August 28, 2017
COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease
News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale
Todd Neale
August 27, 2017
Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions
News Conference News SCCT 2017

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Yael L. Maxwell
Yael L. Maxwell
July 08, 2017
DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting
News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell
Yael L. Maxwell
May 22, 2017
FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo
News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan
Michael O'Riordan
March 17, 2017
Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?
News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox
Caitlin E. Cox
February 17, 2017
Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial
News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox
Caitlin E. Cox
February 15, 2017
Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study
News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox
Caitlin E. Cox
February 10, 2017
Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360
News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox
Caitlin E. Cox
February 07, 2017
Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients
News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox
Caitlin E. Cox
February 07, 2017
Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?
News Conference News ISET 2017

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Caitlin E. Cox
Caitlin E. Cox
February 06, 2017
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2025. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing